USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NUPOTENTIAL, INC.
Address:
340 East Parker Street
BATON ROUGE, LA
Phone:
N/A
URL:
N/A
EIN:
126133749
DUNS:
177487134
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $499,765.00 2
SBIR Phase II $844,722.00 1
STTR Phase I $884,256.00 3

Award List:

A Predictive Model for Nuclear Transfer Reprogramming

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Infigen will use SBIR grant support to develop a model for evaluating the molecular events associated with cellular reprogramming that enables early determination of a cell's probability of developing into a desired organism or tissue. No such model has been… More

A Predictive Model for Nuclear Transfer Reprogramming

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$844,722.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Infigen will use SBIR grant support to develop a model for evaluating the molecular events associated with cellular reprogramming that enables early determination of a cell's probability of developing into a desired organism or tissue. No such model has been… More

Production of cell lines with improved reprogramming potential for SCNT

Award Year / Program / Phase:
2009 / STTR / Phase I
Award Amount:
$244,352.00
Agency:
HHS
Principal Investigator:
Research Institution:
LOUISIANA STATE UNIVERSITY
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): NuPotential will use NIH STTR funds to develop and validate a novel epigenetic-based in vitro system for reprogramming bovine donor cells to improve the efficiency of somatic cell nuclear transfer (SCNT). To accomplish this, NuPotential will alter chromatin… More

Novel Reprogrammed Cells for Differentiation into Cardiomyocytes

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$499,765.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): NuPotential will use SBIR funds to improve a patent pending method to reprogram cells using a novel small molecule library. Reprogrammed cells generated using this improved method will be referred to as NuPiPSsm cell s. In addition, NuPotential will partner… More

Development of a human Oct-4 gene-targeted reporter cell line

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$310,768.00
Agency:
HHS
Principal Investigator:
Gregory Leno – 225-615-8954
Research Institution:
University Of Iowa
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): NuPotential, Inc. will use NIH STTR funds to generate and validate human Oct-4 gene-targeted reporter cell lines that will provide superior predictive indexing of gene transcription for the identification of efficient reprogramming-competent epi-drugs. To… More

Improving Epigenetic-based Cell Reprogramming with Proteasome Inhibition

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$329,136.00
Agency:
HHS
Principal Investigator:
Jaroslaw Staszkiewicz – 225-615-8958
Research Institution:
Lsu Pennington Biomedical Research Ctr
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Direct reprogramming of somatic cells to induced pluripotent stem (iPS) cells has been demonstrated by viral transduction of exogenous transcription factors. These initial demonstrations have provided valuable insight into molecular mechanisms of somatic cell… More